Cargando…

The Correlation Between the Immune and Epithelial-Mesenchymal Transition Signatures Suggests Potential Therapeutic Targets and Prognosis Prediction Approaches in Kidney Cancer

Both epithelial-mesenchymal transition (EMT) and immune regulation are important biological process in malignant tumours. The current research aims to comprehensively explore the potential association between the epithelial-mesenchymal transition (EMT) signature and immune checkpoint signature and i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Jiayu, Liu, Zhihong, Zou, Zijun, Tang, Yongquan, Zhou, Chuan, Yang, Jian, Wei, Xin, Lu, Yiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919934/ https://www.ncbi.nlm.nih.gov/pubmed/29700419 http://dx.doi.org/10.1038/s41598-018-25002-w

Ejemplares similares

Knockdown of ribosomal protein S15A inhibits human kidney cancer cell growth in vitro and in vivo
por: Liang, Jiayu, et al.
Publicado: (2019)

Early post-operative serum albumin level predicts survival after curative nephrectomy for kidney cancer: a retrospective study
por: Tang, Yongquan, et al.
Publicado: (2018)

A Novel Epithelial-Mesenchymal Transition Gene Signature Correlated With Prognosis, and Immune Infiltration in Hepatocellular Carcinoma
por: Kong, Weihao, et al.
Publicado: (2022)

Benefits of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A Systematic Review and Meta-Analysis
por: Tang, Yongquan, et al.
Publicado: (2018)

An epithelial–mesenchymal transition-related long noncoding RNA signature correlates with the prognosis and progression in patients with bladder cancer
por: Tong, Hang, et al.
Publicado: (2021)

Development and validation of an epithelial–mesenchymal transition-related gene signature for predicting prognosis
por: Zhou, De-Hua, et al.
Publicado: (2022)

An epithelial–mesenchymal transition-related mRNA signature associated with the prognosis, immune infiltration and therapeutic response of colon adenocarcinoma
por: Zhang, Yu, et al.
Publicado: (2023)

Epithelial-mesenchymal transition-related gene signature for prognosis of lung squamous cell carcinoma
por: Yu, Hongmin, et al.
Publicado: (2023)

Role of the Epithelial-Mesenchymal Transition in Bladder Cancer: From Prognosis to Therapeutic Target
por: Yun, Seok Joong, et al.
Publicado: (2013)

An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients
por: Zhu, Gongmin, et al.
Publicado: (2021)

Discovery and Validation of an Epithelial-Mesenchymal Transition-Based Signature in Gastric Cancer by Genomics and Prognosis Analysis
por: Xu, Huiyong, et al.
Publicado: (2021)

Identification of a Novel Epithelial–Mesenchymal Transition-Related Gene Signature for Endometrial Carcinoma Prognosis
por: Ruan, Tianyuan, et al.
Publicado: (2022)

Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts Prognosis and Response to Immunotherapy in Gastric Cancer
por: Song, Junquan, et al.
Publicado: (2022)

A novel epithelial–mesenchymal transition gene signature for the immune status and prognosis of hepatocellular carcinoma
por: Shi, Yanlong, et al.
Publicado: (2022)

Clinical significance of prognostic nutritional index in renal cell carcinomas
por: Tang, Yongquan, et al.
Publicado: (2021)

Macrophage-Specific Cathepsin as a Marker Correlated with Prognosis and Tumor Microenvironmental Characteristics of Clear Cell Renal Cell Carcinoma
por: Zhang, Fan, et al.
Publicado: (2022)

A novel epithelial-mesenchymal transition-related gene signature for prognosis prediction in patients with lung adenocarcinoma
por: Feng, Shengyu, et al.
Publicado: (2022)

Comprehensive Characterization of Immune Landscape Based on Epithelial-Mesenchymal Transition Signature in OSCC: Implication for Prognosis and Immunotherapy
por: Zhang, Si-yuan, et al.
Publicado: (2021)

Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts Prognosis and Response to Chemotherapy in Acute Myeloid Leukemia
por: Qu, Shuang, et al.
Publicado: (2023)

Effects of ZnT8 on epithelial-to-mesenchymal transition and tubulointerstitial fibrosis in diabetic kidney disease
por: Zhang, Xiuli, et al.
Publicado: (2020)

Genomics and Prognosis Analysis of Epithelial-Mesenchymal Transition in Glioma
por: Tao, Chuming, et al.
Publicado: (2020)

Exosomes Regulate the Epithelial–Mesenchymal Transition in Cancer
por: Jiang, Jingwen, et al.
Publicado: (2022)

Assessment of epithelial–mesenchymal transition signatures in oral submucous fibrosis
por: Prasad, R Shesha, et al.
Publicado: (2019)

Epithelial-mesenchymal transition gene signature is associated with prognosis and tumor microenvironment in head and neck squamous cell carcinoma
por: Jung, Ah Ra, et al.
Publicado: (2020)

Epithelial-Mesenchymal Transition Gene Signature Is Associated with Neoadjuvant Chemoradiotherapy Resistance and Prognosis of Esophageal Squamous Cell Carcinoma
por: Song, Kewei, et al.
Publicado: (2022)

Systematic establishment and verification of an epithelial-mesenchymal transition gene signature for predicting prognosis of oral squamous cell carcinoma
por: Ai, Jun, et al.
Publicado: (2023)

Expression of the prognostic marker IL‐8 correlates with the immune signature and epithelial‐mesenchymal transition in breast cancer
por: Liao, Huifeng, et al.
Publicado: (2023)

Monoamine Oxidase B Expression Correlates with a Poor Prognosis in Colorectal Cancer Patients and Is Significantly Associated with Epithelial-to-Mesenchymal Transition-Related Gene Signatures
por: Yang, Yi-Chieh, et al.
Publicado: (2020)

Identification of an amino acid metabolism-associated gene signature predicting the prognosis and immune therapy response of clear cell renal cell carcinoma
por: Zhang, Fan, et al.
Publicado: (2022)

Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients
por: Liang, Jiayu, et al.
Publicado: (2019)

The network of pluripotency, epithelial–mesenchymal transition, and prognosis of breast cancer
por: Voutsadakis, Ioannis A
Publicado: (2015)

Identification of Epithelial-Mesenchymal Transition-Related lncRNAs that Associated With the Prognosis and Immune Microenvironment in Colorectal Cancer
por: Liu, Chuan, et al.
Publicado: (2021)

CD146 Expression Correlates with Epithelial-Mesenchymal Transition Markers and a Poor Prognosis in Gastric Cancer
por: Liu, Wen-Fang, et al.
Publicado: (2012)

MAGEC2 Correlates With Unfavorable Prognosis And Promotes Tumor Development In HCC Via Epithelial-Mesenchymal Transition
por: Gu, Xuefeng, et al.
Publicado: (2019)

PIK3CD correlates with prognosis, epithelial–mesenchymal transition and tumor immune infiltration in breast carcinoma
por: He, Wenxing, et al.
Publicado: (2023)

Novel clinical therapeutics targeting the epithelial to mesenchymal transition
por: Kothari, Anai N, et al.
Publicado: (2014)

Epithelial–Mesenchymal Transition-Mediated Tumor Therapeutic Resistance
por: Xu, Zhimin, et al.
Publicado: (2022)

Molecular and pathological signatures of epithelial–mesenchymal transitions at the cancer invasion front
por: De Wever, Olivier, et al.
Publicado: (2008)

Epithelial–Mesenchymal Transition Gene Signature Related to Prognostic in Colon Adenocarcinoma
por: Busuioc, Constantin, et al.
Publicado: (2021)

A polyamine metabolism risk signature for predicting the prognosis and immune therapeutic response of kidney cancer
por: Li, Bo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1oekbalvec33mnlaqa56n57nmi